Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Cameron T. Lambert"'
Autor:
Cameron T. Lambert, MD, Divyang Patel, MD, Joseph M. Bumgarner, MD, Mohamed Kanj, MD, Daniel Cantillon, MD, FHRS, Walid Saliba, MD, Ayman Hussein, MD, FHRS, Bryan Baranowski, MD, Thomas Dresing, MD, Mina K. Chung, MD, FHRS, John Rickard, MD, MPH, Niraj Varma, MD, PhD, Thomas Callahan, MD, FHRS, David Martin, MD, Patrick Tchou, MD, FHRS, Mandeep Bhargava, MD, Kathy Wolski, MS, Oussama Wazni, MD, FHRS, Khaldoun G. Tarakji, MD, MPH, FHRS
Publikováno v:
Cardiovascular Digital Health Journal, Vol 2, Iss 2, Pp 92-100 (2021)
Background: Direct-to-consumer devices allow patients to record electrocardiograms (ECG) and detect atrial fibrillation (AF). Clinical adoption of these devices has been limited owing to the lack of efficient workflow. Objective: To assess a new care
Externí odkaz:
https://doaj.org/article/afddd06cda1c4b1abee55b09d752a9c9
Autor:
Niraj Varma, Walid Saliba, David O. Martin, Oussama M. Wazni, Bryan Baranowski, Joseph M. Bumgarner, Khaldoun G. Tarakji, Thomas Dresing, Mina K. Chung, Patrick J. Tchou, Cameron T. Lambert, Kathy Wolski, Thomas Callahan, Divyang Patel, Mohamed Kanj, Mandeep Bhargava, Daniel J. Cantillon, John Rickard, Ayman A. Hussein
Publikováno v:
Cardiovascular Digital Health Journal, Vol 2, Iss 2, Pp 92-100 (2021)
Background Direct-to-consumer devices allow patients to record electrocardiograms (ECG) and detect atrial fibrillation (AF). Clinical adoption of these devices has been limited owing to the lack of efficient workflow. Objective To assess a new care m
Autor:
Cameron T. Lambert, Richard A. Grimm
Publikováno v:
Diastology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6391910a4f28f9f85aa82b04fb71c3f4
https://doi.org/10.1016/b978-0-323-64067-1.00030-9
https://doi.org/10.1016/b978-0-323-64067-1.00030-9
Advances in cardiac implantable electronic device infection prevention: should we push the envelope?
Publikováno v:
Future Cardiology. 14:359-366
Cardiac implantable electronic devices (CIEDs) including pacemakers, implantable cardioverter defibrillators and loop recorders have become widespread adjuncts in the care of patients with cardiovascular disease. CIEDs provide increased diagnostic yi
Autor:
Khaldoun G. Tarakji, Daniel J. Cantillon, Ayman A. Hussein, Kathy Wolski, Oussama M. Wazni, Joseph M. Bumgarner, Bryan Baranowski, Cameron T. Lambert, Bruce D. Lindsay
Publikováno v:
Journal of the American College of Cardiology. 71:2381-2388
Background The Kardia Band (KB) is a novel technology that enables patients to record a rhythm strip using an Apple Watch (Apple, Cupertino, California). The band is paired with an app providing automated detection of atrial fibrillation (AF). Object
Publikováno v:
Cleveland Clinic Journal of Medicine. 84:47-53
Increasing numbers of patients with cardiac disease have improved quality of life and longevity as a result of cardiac implantable electronic devices (CIEDs). CIED infections can involve the generator pocket, bloodstream, or cardiac structures and oc
Autor:
Wael A. Jaber, Cameron T. Lambert
Publikováno v:
Journal of Nuclear Cardiology. 25:351-355
Autor:
Stacy Poe, Henry Hilow, Cameron T. Lambert, Divyang Patel, Walid Saliba, Ayman A. Hussein, Michelle Moufawad, Oussama M. Wazni, Khaldoun G. Tarakji, Bryan Baranowski, Mandeep Bhargava, Daniel J. Cantillon, John Rickard, Peter T Hu, Bruce L. Wilkoff
Publikováno v:
Pacing and clinical electrophysiology : PACEREFERENCES. 43(1)
Background Advancement of digital technology now allows patients to have access to data from their cardiac implantable electronic devices (CIEDs). However, patients' understanding regarding CIED data and perceived personal usability remain unclear. T
Publikováno v:
Circulation. Heart failure. 11(8)
Autor:
Jefferson Baer, Pratik B. Sandesara, Laurence S. Sperling, Danny J. Eapen, Cameron T. Lambert, Maria Carolina Gongora, Ijeoma Isiadinso, Neal K. Bhatia
Publikováno v:
European cardiology. 9(2)
Familial hypercholesterolaemia is an autosomal-dominant disorder associated with mutations in the LDL receptor gene resulting in markedly elevated plasma low-density lipoprotein cholesterol levels. FH is significantly underrecognised with as many as